Article
The SYNGAP1 3'UTR Variant in ALS Patients Causes Aberrant SYNGAP1 Splicing and Dendritic Spine Loss by Recruiting HNRNPK.
The Journal of neuroscience : the official journal of the Society for Neuroscience - 23 Nov 2022
Yokoi Satoshi, Ito Takuji, Sahashi Kentaro, Nakatochi Masahiro, Nakamura Ryoichi, Tohnai Genki, Fujioka Yusuke, Ishigaki Shinsuke, Udagawa Tsuyoshi, Izumi Yuishin, Morita Mitsuya, Kano Osamu, Oda Masaya, Sone Takefumi, Okano Hideyuki, Atsuta Naoki, Katsuno Masahisa, Okada Yohei, Sobue Gen
Abstract excerpt
Fused in sarcoma (FUS) is a pathogenic RNA-binding protein in amyotrophic lateral sclerosis (ALS). We previously reported that FUS stabilizes Synaptic Ras-GTPase activating protein 1 (Syngap1) mRNA at its 3' untranslated region (UTR) and maintains spine maturation. To elucidate the pathologic roles of this mechanism in ALS patients, we identified the SYNGAP1 3'UTR variant rs149438267 in seven (four males and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
